{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:20:58Z","timestamp":1783693258141,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Taipei, Taichung, Kaohsiung Veterans General Hospital, Tri-Service General Hospital, Academia Sinica Joint Research Program","award":["VTA112-A-2-2"],"award-info":[{"award-number":["VTA112-A-2-2"]}]},{"name":"Ministry of Science and Technology, Taiwan","award":["112-2314-B-075-034-MY3"],"award-info":[{"award-number":["112-2314-B-075-034-MY3"]}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V113C-018"],"award-info":[{"award-number":["V113C-018"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taiwan Motor Neuron Disease Association"},{"name":"Center for Intelligent Drug Systems and Smart Bio-devices"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01744-4","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T03:24:35Z","timestamp":1745983475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Early presentation of spastic paraparesis in individuals carrying PSEN1 mutations: a clinical and genetic analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Kang-Yang","family":"Jih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Rong","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Ling","family":"Fuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse-Hao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Shuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Yu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"issue":"10","key":"1744_CR1","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jama.1997.03540340059034","volume":"277","author":"CL Lendon","year":"1997","unstructured":"Lendon CL, Ashall F, Goate AM. Exploring the etiology of alzheimer disease using molecular genetics. JAMA. 1997;277(10):825\u201331.","journal-title":"JAMA"},{"issue":"1","key":"1744_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt59","volume":"3","author":"RJ Bateman","year":"2011","unstructured":"Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, et al. Autosomal-dominant Alzheimer\u2019s disease: a review and proposal for the prevention of Alzheimer\u2019s disease. Alzheimers Res Ther. 2011;3(1):1.","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"1744_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/jmg.2005.033456","volume":"42","author":"G Raux","year":"2005","unstructured":"Raux G, Guyant-Marechal L, Martin C, Bou J, Penet C, Brice A, et al. Molecular diagnosis of autosomal dominant early onset Alzheimer\u2019s disease: an update. J Med Genet. 2005;42(10):793\u20135.","journal-title":"J Med Genet"},{"issue":"3","key":"1744_CR4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neurol.2008.10.019","volume":"165","author":"L Guyant-Marechal","year":"2008","unstructured":"Guyant-Marechal L, Campion D, Hannequin D. Alzheimer disease: autosomal dominant forms. Rev Neurol. 2008;165(3):223\u201331.","journal-title":"Rev Neurol"},{"key":"1744_CR5","doi-asserted-by":"crossref","unstructured":"Kelleher RJ 3rd, Shen J. Presenilin-1 mutations and Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2017;114(4):629\u201331.","DOI":"10.1073\/pnas.1619574114"},{"issue":"1","key":"1744_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1532-5415.1987.tb01315.x","volume":"35","author":"FJ Huff","year":"1987","unstructured":"Huff FJ, Growdon JH, Corkin S, Rosen TJ. Age at onset and rate of progression of Alzheimer\u2019s disease. J Am Geriatr Soc. 1987;35(1):27\u201330.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"1744_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","volume":"83","author":"DC Ryman","year":"2014","unstructured":"Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, et al. Symptom onset in autosomal dominant alzheimer disease: a systematic review and meta-analysis. Neurology. 2014;83(3):253\u201360.","journal-title":"Neurology"},{"issue":"13","key":"1744_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/S1474-4422(16)30229-0","volume":"15","author":"M Tang","year":"2016","unstructured":"Tang M, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, et al. Neurological manifestations of autosomal dominant Familial alzheimer\u2019s disease: a comparison of the published literature with the dominantly inherited alzheimer network observational study (DIAN-OBS). Lancet Neurol. 2016;15(13):1317\u201325.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1744_CR9","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/alz.12684","volume":"19","author":"J Voglein","year":"2023","unstructured":"Voglein J, Franzmeier N, Morris JC, Dieterich M, McDade E, Simons M, et al. Pattern and implications of neurological examination findings in autosomal dominant alzheimer disease. Alzheimers Dement. 2023;19(2):632\u201345.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1744_CR10","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/brain\/awz050","volume":"142","author":"J Voglein","year":"2019","unstructured":"Voglein J, Paumier K, Jucker M, Preische O, McDade E, Hassenstab J, et al. Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer\u2019s disease. Brain. 2019;142(5):1429\u201340.","journal-title":"Brain"},{"issue":"4","key":"1744_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nm0498-452","volume":"4","author":"R Crook","year":"1998","unstructured":"Crook R, Verkkoniemi A, Perez-Tur J, Mehta N, Baker M, Houlden H, et al. A variant of Alzheimer\u2019s disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med. 1998;4(4):452\u20135.","journal-title":"Nat Med"},{"issue":"12","key":"1744_CR12","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/jnnp.2007.123026","volume":"78","author":"M Anheim","year":"2007","unstructured":"Anheim M, Hannequin D, Boulay C, Martin C, Campion D, Tranchant C. Ataxic variant of Alzheimer\u2019s disease caused by Pro117Ala PSEN1 mutation. J Neurol Neurosurg Psychiatry. 2007;78(12):1414\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"1744_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-002-0536-6","volume":"104","author":"M Takao","year":"2002","unstructured":"Takao M, Ghetti B, Hayakawa I, Ikeda E, Fukuuchi Y, Miravalle L, et al. A novel mutation (G217D) in the presenilin 1 gene (PSEN1) in a Japanese family: presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum. Acta Neuropathol. 2002;104(2):155\u201370.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"1744_CR14","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.neurobiolaging.2008.01.005","volume":"30","author":"L Bernardi","year":"2009","unstructured":"Bernardi L, Tomaino C, Anfossi M, Gallo M, Geracitano S, Costanzo A, et al. Novel PSEN1 and PGRN mutations in early-onset Familial frontotemporal dementia. Neurobiol Aging. 2009;30(11):1825\u201333.","journal-title":"Neurobiol Aging"},{"issue":"13","key":"1744_CR15","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/S1474-4422(16)30193-4","volume":"15","author":"NS Ryan","year":"2016","unstructured":"Ryan NS, Nicholas JM, Weston PSJ, Liang Y, Lashley T, Guerreiro R, et al. Clinical phenotype and genetic associations in autosomal dominant Familial Alzheimer\u2019s disease: a case series. Lancet Neurol. 2016;15(13):1326\u201335.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1744_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00415-005-0019-5","volume":"253","author":"AJ Larner","year":"2006","unstructured":"Larner AJ, Doran M. Clinical phenotypic heterogeneity of Alzheimer\u2019s disease associated with mutations of the presenilin-1 gene. J Neurol. 2006;253(2):139\u201358.","journal-title":"J Neurol"},{"issue":"1","key":"1744_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1212\/01.WNL.0000040252.43269.83","volume":"60","author":"A Assini","year":"2003","unstructured":"Assini A, Terreni L, Borghi R, Giliberto L, Piccini A, Loqui D, et al. Pure spastic paraparesis associated with a novel presenilin 1 R278K mutation. Neurology. 2003;60(1):150.","journal-title":"Neurology"},{"issue":"3","key":"1744_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.neulet.2004.07.057","volume":"368","author":"S Hattori","year":"2004","unstructured":"Hattori S, Sakuma K, Wakutani Y, Wada K, Shimoda M, Urakami K, et al. A novel presenilin 1 mutation (Y154N) in a patient with early onset Alzheimer\u2019s disease with spastic paraparesis. Neurosci Lett. 2004;368(3):319\u201322.","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"1744_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jns.2007.04.013","volume":"260","author":"A Raman","year":"2007","unstructured":"Raman A, Lin X, Suri M, Hewitt M, Constantinescu CS, Phillips MF. A presenilin 1 mutation (Arg278Ser) associated with early onset Alzheimer\u2019s disease and spastic paraparesis. J Neurol Sci. 2007;260(1\u20132):78\u201382.","journal-title":"J Neurol Sci"},{"issue":"12","key":"1744_CR20","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1474-4422(08)70258-8","volume":"7","author":"S Salinas","year":"2008","unstructured":"Salinas S, Proukakis C, Crosby A, Warner TT. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 2008;7(12):1127\u201338.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1744_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41525-021-00178-9","volume":"6","author":"CY Wei","year":"2021","unstructured":"Wei CY, Yang JH, Yeh EC, Tsai MF, Kao HJ, Lo CZ, et al. Genetic profiles of 103,106 individuals in the Taiwan biobank provide insights into the health and history of Han Chinese. NPJ Genom Med. 2021;6(1):10.","journal-title":"NPJ Genom Med"},{"issue":"4","key":"1744_CR22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.15616\/BSL.2018.24.4.418","volume":"24","author":"H Kang","year":"2018","unstructured":"Kang H, Kim W-G, Yang G-S, Kim H-W, Jeong J-E, Yoon H-J, et al. VGG-based BAPL score classification of 18F-florbetaben amyloid brain PET. Biomedical Sci Lett. 2018;24(4):418\u201325.","journal-title":"Biomedical Sci Lett"},{"issue":"3","key":"1744_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-mental State. A practical method for grading the cognitive State.of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"1744_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/S1041610294001602","volume":"6","author":"EL Teng","year":"1994","unstructured":"Teng EL, Hasegawa K, Homma A, Imai Y, Larson E, Graves A, et al. The cognitive abilities screening instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr. 1994;6(1):45\u201358. discussion 62.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"1744_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12877-024-04810-y","volume":"24","author":"WJ Lyu","year":"2024","unstructured":"Lyu WJ, Chiu PY, Liu CH, Liao YC, Chang HT. Determining optimal cutoff scores of cognitive abilities screening instrument to identify dementia and mild cognitive impairment in Taiwan. BMC Geriatr. 2024;24(1):216.","journal-title":"BMC Geriatr"},{"issue":"4","key":"1744_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000525615","volume":"51","author":"YC Wei","year":"2022","unstructured":"Wei YC, Chen CK, Lin C, Chen PY, Hsu PC, Lin CP, et al. Normative data of Mini-Mental state examination, Montreal cognitive assessment, and Alzheimer\u2019s disease assessment Scale-Cognitive subscale of Community-Dwelling older adults in Taiwan. Dement Geriatr Cogn Disord. 2022;51(4):365\u201376.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"1744_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1212\/01.wnl.0000191360.08881.12","volume":"66","author":"MG Marrosu","year":"2006","unstructured":"Marrosu MG, Floris G, Costa G, Schirru L, Spinicci G, Cherchi MV, et al. Dementia, pyramidal system involvement, and leukoencephalopathy with a presenilin 1 mutation. Neurology. 2006;66(1):108\u201311.","journal-title":"Neurology"},{"issue":"5","key":"1744_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"5","key":"1744_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/jnen\/60.5.483","volume":"60","author":"A Verkkoniemi","year":"2001","unstructured":"Verkkoniemi A, Kalimo H, Paetau A, Somer M, Iwatsubo T, Hardy J, et al. Variant alzheimer disease with spastic paraparesis: neuropathological phenotype. J Neuropathol Exp Neurol. 2001;60(5):483\u201392.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"1744_CR30","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1007\/s00415-022-11125-8","volume":"269","author":"M Altuna","year":"2022","unstructured":"Altuna M, Larumbe R, Zelaya MV, Moreno S, Garc\u00eda-Solaesa V, Mendioroz M, et al. Progressive cognitive impairment and Familial spastic paraparesis due to PRESENILIN 1 mutation: anatomoclinical characterization. J Neurol. 2022;269(9):4853\u201362.","journal-title":"J Neurol"},{"issue":"3","key":"1744_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/WAD.0b013e3181732399","volume":"22","author":"LA Rudzinski","year":"2008","unstructured":"Rudzinski LA, Fletcher RM, Dickson DW, Crook R, Hutton ML, Adamson J, et al. Early onset Familial alzheimer disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1. Alzheimer Disease Assoc Disorders. 2008;22(3):299\u2013307.","journal-title":"Alzheimer Disease Assoc Disorders"},{"key":"1744_CR32","doi-asserted-by":"crossref","unstructured":"Ryan NS, Bastos-Leite AJ, Rohrer JD, Werring DJ, Fox NC, Rossor MN, et al. Cerebral microbleeds in Familial Alzheimer\u2019s disease. Brain. 2012;135(Pt 1):e201. author reply e2.","DOI":"10.1093\/brain\/awr126"},{"issue":"3","key":"1744_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1744_CR34","doi-asserted-by":"publisher","first-page":"e12186","DOI":"10.1002\/dad2.12186","volume":"13","author":"V Chelban","year":"2021","unstructured":"Chelban V, Breza M, Szaruga M, Vandrovcova J, Murphy D, Lee CJ, et al. Spastic paraplegia preceding PSEN1-related Familial Alzheimer\u2019s disease. Alzheimers Dement (Amst). 2021;13(1):e12186.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"1744_CR35","doi-asserted-by":"publisher","first-page":"19769","DOI":"10.1038\/s41598-020-76794-9","volume":"10","author":"YS Lin","year":"2020","unstructured":"Lin YS, Cheng CY, Liao YC, Hong CJ, Fuh JL. Mutational analysis in Familial Alzheimer\u2019s disease of Han Chinese in Taiwan with a predominant mutation PSEN1 p.Met146Ile. Sci Rep. 2020;10(1):19769.","journal-title":"Sci Rep"},{"key":"1744_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12883-014-0216-x","volume":"14","author":"MY Lan","year":"2014","unstructured":"Lan MY, Chang YY, Yeh TH, Lai SC, Liou CW, Kuo HC, et al. High frequency of SPG4 in Taiwanese families with autosomal dominant hereditary spastic paraplegia. BMC Neurol. 2014;14:216.","journal-title":"BMC Neurol"},{"issue":"4","key":"1744_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/acn3.51019","volume":"7","author":"CT Chou","year":"2020","unstructured":"Chou CT, Soong BW, Lin KP, Tsai YS, Jih KY, Liao YC, et al. Clinical characteristics of Taiwanese patients with hereditary spastic paraplegia type 5. Ann Clin Transl Neurol. 2020;7(4):486\u201396.","journal-title":"Ann Clin Transl Neurol"},{"key":"1744_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.parkreldis.2021.05.004","volume":"87","author":"SL Hsu","year":"2021","unstructured":"Hsu SL, Hsueh HW, Chen SY, Chang YY, Tan S, Hong CT, et al. Clinical and genetic characterization of hereditary spastic paraplegia type 3A in Taiwan. Parkinsonism Relat Disord. 2021;87:87\u201391.","journal-title":"Parkinsonism Relat Disord"},{"key":"1744_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neurobiolaging.2016.07.030","volume":"47","author":"SK Soosman","year":"2016","unstructured":"Soosman SK, Joseph-Mathurin N, Braskie MN, Bordelon YM, Wharton D, Casado M, et al. Widespread white matter and conduction defects in PSEN1-related spastic paraparesis. Neurobiol Aging. 2016;47:201\u20139.","journal-title":"Neurobiol Aging"},{"issue":"11","key":"1744_CR40","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/jnen\/60.11.1051","volume":"60","author":"TV Le","year":"2001","unstructured":"Le TV, Crook R, Hardy J, Dickson DW. Cotton wool plaques in non-familial late-onset alzheimer disease. J Neuropathol Exp Neurol. 2001;60(11):1051\u201361.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1744_CR41","doi-asserted-by":"crossref","unstructured":"Saint-Aubert L, Payoux P, Hannequin D, Barbeau EJ, Campion D, Delisle MB et al. MR, (18)F-FDG, and (18)F-AV45 PET correlate with AD PSEN1 original phenotype. Alzheimer Dis Assoc Disord. 2013;27(1):91\u2013\u20094.","DOI":"10.1097\/WAD.0b013e318251d87c"},{"issue":"5","key":"1744_CR42","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F","volume":"48","author":"H Houlden","year":"2000","unstructured":"Houlden H, Baker M, McGowan E, Lewis P, Hutton M, Crook R, et al. Variant Alzheimer\u2019s disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol. 2000;48(5):806\u20138.","journal-title":"Ann Neurol"},{"issue":"6","key":"1744_CR43","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1097\/00001756-199704140-00043","volume":"8","author":"JB Kwok","year":"1997","unstructured":"Kwok JB, Taddei K, Hallupp M, Fisher C, Brooks WS, Broe GA, et al. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer\u2019s disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. NeuroReport. 1997;8(6):1537\u201342.","journal-title":"NeuroReport"},{"issue":"2","key":"1744_CR44","doi-asserted-by":"publisher","first-page":"fcad030","DOI":"10.1093\/braincomms\/fcad030","volume":"5","author":"JM Ringman","year":"2023","unstructured":"Ringman JM, Dorrani N, Fernandez SG, Signer R, Martinez-Agosto J, Lee H, et al. Characterization of spastic paraplegia in a family with a novel PSEN1 mutation. Brain Commun. 2023;5(2):fcad030.","journal-title":"Brain Commun"},{"key":"1744_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms231810970","volume":"23","author":"J Bagaria","year":"2022","unstructured":"Bagaria J, Bagyinszky E, An SSA. Genetics, functions, and clinical impact of Presenilin-1 (PSEN1) gene. Int J Mol Sci. 2022;23:18.","journal-title":"Int J Mol Sci"},{"key":"1744_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1326-1-4","volume":"1","author":"KS Vetrivel","year":"2006","unstructured":"Vetrivel KS, Zhang YW, Xu H, Thinakaran G. Pathological and physiological functions of presenilins. Mol Neurodegener. 2006;1:4.","journal-title":"Mol Neurodegener"},{"issue":"12","key":"1744_CR47","first-page":"1437","volume":"81","author":"S Dhillon","year":"2021","unstructured":"Dhillon S, Aducanumab. First Approval Drugs. 2021;81(12):1437\u201343.","journal-title":"First Approval Drugs"},{"issue":"1","key":"1744_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"18","key":"1744_CR49","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW, et al. Donanemab in early Alzheimer\u2019s disease. N Engl J Med. 2021;384(18):1691\u2013704.","journal-title":"N Engl J Med"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01744-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:03:31Z","timestamp":1745985811000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01744-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1744"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01744-4","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Taipei Veterans General Hospital (IRB No. 2017-02-008A) and was conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. Written informed consent was obtained from all participants prior to their participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}